NEUROENDOCRINE CANCER
Clinical trials for NEUROENDOCRINE CANCER explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CANCER trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ZG006 targets tough cancers in early human trial
Disease control Recruiting nowThis study tests an experimental drug called ZG006 in people with advanced small cell lung cancer or neuroendocrine carcinoma. The first part finds a safe dose, and the second part checks how well it shrinks tumors. About 265 adults aged 18 to 75 with good performance status are …
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug candidate BL-M14D1 enters human trials for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug called BL-M14D1 in people with advanced small cell lung cancer or other neuroendocrine cancers that have spread. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 120 adults will take part, a…
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New scan could spot hidden cancers more clearly
Diagnosis Recruiting nowThis study tests a special PET scan that targets a protein called DLL3, found on some neuroendocrine cancer cells. The goal is to see if this scan can find tumors more accurately than current imaging methods. About 60 adults with suspected or confirmed neuroendocrine cancer will …
Matched conditions: NEUROENDOCRINE CANCER
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated May 26, 2026 02:30 UTC